Hongyu Chen Selected Research

Stroke (Strokes)

3/2021	Up-regulating lncRNA OIP5-AS1 protects neuron injury against cerebral hypoxia-ischemia induced inflammation and oxidative stress in microglia/macrophage through activating CTRP3 via sponging miR-186-5p.
1/2020	Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongyu Chen Research Topics

Disease

62	Neoplasms (Cancer) 02/2024 - 09/2010
14	Infections 03/2024 - 02/2014
11	Inflammation (Inflammations) 01/2023 - 07/2015
10	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2017
8	Breast Neoplasms (Breast Cancer) 07/2022 - 11/2013
7	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2018
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2010
6	Chronic Renal Insufficiency 10/2023 - 01/2017
5	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2020
5	Carcinogenesis 11/2022 - 01/2015
5	Chronic Hepatitis B 01/2022 - 01/2020
5	Diabetic Nephropathies (Diabetic Nephropathy) 11/2018 - 06/2013
4	Cognitive Dysfunction 03/2024 - 01/2023
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2021
4	Osteoarthritis 01/2024 - 03/2017
4	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2019
4	Heart Failure 12/2023 - 01/2022
4	Adenocarcinoma of Lung 01/2023 - 10/2017
4	Fibrosis (Cirrhosis) 01/2023 - 11/2020
4	Necrosis 01/2022 - 01/2019
3	Thrombosis (Thrombus) 04/2024 - 01/2022
3	Glioma (Gliomas) 02/2024 - 01/2021
3	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2022
3	Ischemic Stroke 01/2024 - 01/2022
3	Disease Progression 12/2023 - 01/2018
3	Peritonitis 07/2023 - 01/2017
3	Osteoporosis 01/2023 - 01/2020
3	Phototoxic Dermatitis (Phototoxicity) 01/2023 - 01/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2017
3	Albuminuria 01/2019 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 08/2015
3	Proteinuria 07/2015 - 01/2011
2	Acquired Immunodeficiency Syndrome (AIDS) 07/2024 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2023
2	Pathologic Processes 01/2024 - 01/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2021
2	Bacterial Infections (Bacterial Infection) 02/2023 - 01/2022
2	Edema (Dropsy) 01/2023 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 02/2024 - 09/2015
15	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2012
6	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 01/2020
6	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2021
5	LipidsIBA 01/2024 - 11/2020
5	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2020
5	CytokinesIBA 08/2023 - 11/2018
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2014
5	Therapeutic UsesIBA 01/2022 - 06/2018
4	VaccinesIBA 02/2024 - 08/2021
4	Messenger RNA (mRNA)IBA 01/2024 - 01/2012
4	Circular RNAIBA 01/2024 - 01/2020
4	LigandsIBA 11/2022 - 10/2014
4	CreatinineIBA 01/2020 - 07/2015
3	Peptides (Polypeptides)IBA 03/2024 - 01/2023
3	Phosphotransferases (Kinase)IBA 03/2024 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2019
3	AntigensIBA 02/2024 - 01/2022
3	SaltsIBA 01/2024 - 10/2021
3	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2017
3	AcidsIBA 02/2023 - 01/2016
3	ChitosanIBA 02/2023 - 05/2016
3	CalciumIBA 01/2023 - 09/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2021
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2018
3	pgRNAIBA 01/2022 - 01/2020
3	Oxygen (Dioxygen)IBA 03/2021 - 02/2014
3	CateninsIBA 01/2020 - 04/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 01/2011
3	CatecholaminesIBA 01/2018 - 06/2013
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2018 - 10/2014
3	Trastuzumab (Herceptin)FDA Link 03/2015 - 06/2013
2	TeaIBA 07/2024 - 10/2022
2	6,7-dihydroxyflavoneIBA 03/2024 - 01/2022
2	TropomyosinIBA 03/2024 - 01/2022
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024 - 01/2023
2	NanovaccinesIBA 02/2024 - 01/2022
2	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 10/2023
2	SmokeIBA 01/2024 - 01/2021
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2024 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 11/2022
2	FlavonoidsIBA 12/2023 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 09/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 07/2023 - 01/2018
2	Estrogen ReceptorsIBA 04/2023 - 01/2020
2	Estrogens (Estrogen)FDA Link 04/2023 - 01/2023
2	Liposomes (Liposome)IBA 04/2023 - 01/2020
2	Hormones (Hormone)IBA 01/2023 - 01/2020
2	EnzymesIBA 01/2023 - 09/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 07/2019
2	BilirubinIBA 01/2023 - 11/2020

Therapy/Procedure

34	Therapeutics 02/2024 - 02/2013
13	Drug Therapy (Chemotherapy) 01/2024 - 02/2013
7	Photochemotherapy (Photodynamic Therapy) 01/2024 - 01/2016
5	Renal Dialysis (Hemodialysis) 10/2023 - 09/2014
5	Immunotherapy 08/2023 - 01/2023
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2023 - 06/2013
4	Precision Medicine 04/2022 - 01/2014
3	Radiotherapy 01/2022 - 01/2014
2	Electrodes (Electrode) 03/2024 - 05/2023